Transient down-regulation of NMDA receptor subunit gene expression in the rat retina following NMDA-induced neurotoxicity is attenuated in the presence of the non-competitive NMDA receptor antagonist MK-801

Experimental Eye Research

Volumn 72, Issue 5, 2001, Pages 547-558

  Goebel, D J ^a   Poosch, M S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Excitotoxicity; Gene expression; Immunoprecipitation; Nuclease protection assay; Western blot

Indexed keywords

DIZOCILPINE; GENE PRODUCT; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN NR2C; PROTEIN NR2D; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; IMMUNOPRECIPITATION; MALE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; RETINA; RETINA ROD; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0034781267     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.2001.0981     Document Type: Article

References (81)

1. Transfection of N-methyl-D-aspartate receptors in a nonneuronal cell line leads to cell death
2. Neuroprotection after brain ischemia: Role of competitive N-methyl-D-aspartate antagonists
3. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia
4. Expression of NMDA and highaffinity kainate receptor subunit mRNAs in the adult rat retina
5. Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: An electron microscope study
6. Pharmacological heterogeneity of NMDA receptors: Characterization of NR1a/NR2D heteromers expressed Xenopus oocytes
7. MK8O1-a neuroprotectant in rat hypertensive eyes
8. Glutamate neurotoxicity and diseases of the nervous system
9. Pharmacology of glutamate nenrotoxicity in cortical cell culture: Attenuation by NMDA antagonists
10. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction
11. Cloning and characterization of χ-1: A developmentally regulated member of a novel class of ionotropic glutamate receptor family
12. Clinicopathologic correlation of laser lesion expansion after treatment of choroidal neovascu]arization
13. Effect of CP 101606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage of cytotoxic brain edema after middle cerebral artery occlusion in the feline brain
14. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death
15. Glutamate in life and death of retinal amacrine cells
16. Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C
17. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate
18. The role of excitatory amino acids and NMDA receptors in traumatic brain injury
19. AlphaCaMKII binding to the C-terminal tail of NMDA receptor subunit NR2A and its modulation by autophosphorylation
20. Mg2+ reduces Nmethyl-D-aspartate neurotoxicity in embryonic chick neural retina in vitro
21. Quantitative gene expression of two types of glycine transporter in the rat CNS
22. com, NR2A, NR2B, NR2C, NR2D and NR3A
23. Immediate and longterm effects of neonatal MK-801 treatment on nonspatial learning
24. N-methyl-D-aspartate-mediated glutamate toxicity in the developing rabbit retina
25. 2+ toxicity is blocked by the N-methyl-D-aspartate antagonist MK-801
26. Localization and developmental expression of the NMDA receptor subunit NR2A in the mammalian retina
27. Diversity and dynamics of dendritic signaling
28. Decreased expression and functionality of NMDA receptor complexes persist in the CA1, but not in the dentate gyrus after transient cerebral ischemia
29. Molecular characterization of the family of the N-methyl-Daspartate receptor subunits
30. Glutamate antagonist therapy reduces neurological deficits produced by focal central nervous system ischemia
31. Solution hybridization assays for sensitive detection of differentially spliced substance P- and neurokinin A-encoding messenger ribonucleic acids
32. A splice variant form of the N-methyl-D-aspartate (NMDAR1) receptor
33. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
34. Evidence for a tetrameric structure of recombinant NMDA receptors
35. Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents
36. Comparison of delayed administration of competitive and uncompetitive antagonist in preventing NM-DA receptor-mediated neuronal death
37. Suppression of sprouting: An early function of NMDA receptors in the absence of AMPA/kainate receptor activity
38. Ionotropic glutamate receptors in the retina: Moving from molecules to circuits
39. Expression of NMDA receptor subunits tagged with GFP and RFP in HEK293 cells and neurons in culture
40. N-methyl-D-aspartic acid receptor, structure and function
41. MK-801 protects the neonatal brain from hypoxic-ischemic damage
42. MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases N-methyl-D-aspartate recognition site binding in rats
43. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs
44. CP-101606 a potent neuroprotectant selective for forebrain neurons
45. NMDAR1-GFP clusters in cultured hippocampal neurons
46. Developmental and regional expression in the rat brain and functional properties of the four NMDA receptors
47. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
48. Attenuation of focal ischemic brain injury in mice deficient in the εl (NR2A) subunit of NMDA receptor
49. Molecular cloning and characterization of the rat NMDA receptor
50. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against neuronal degeneration in the in vivo adult mammalian retina
51. Alternative splicing generates functionally distinct N-methyl-D-aspartate receptors
52. Glutamate-induced retinal degeneration in neonatal mice: Electron microscopy of the acutely evolving lesion
53. NMDA antagonist neurotoxicity: Mechanism and prevention
54. The anti-excitotoxic effects of certain anesthetics, analgesics and sedative-hypnotics
55. MK-801 powerfully protects against N-methyl-D-aspartate neurotoxicity
56. In vitro hypoxia induces expression of NR2C subunits of the NMDA receptor in rat cortex and hippocampus
57. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NTR2B subunit assemblies expressed in permanently transfected mouse fiberblast cells
58. Activation of NMDA receptor-channels in human retinal Müller glial cells inhibits inward-rectifying potassium currents
59. Excitotoxicity and the NMDA receptor
60. A behavioral model of excitotoxicity: Retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats
61. MK-801 reduces ganglion cell survival but improves visual performance after controlled optic nerve crush
62. The NMDA receptor channel: Molecular design of a coincidence detector
63. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina
64. Histological changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate
65. Alteration in NMDA receptor subunit mRNA expression in vulnerable and resistant regions of in vitro ischemic rat hippocampal slices
66. N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cell in vitro
67. Calcium channel antagonists attenuate NMDA receptor-mediated neurotoxicity of retinal ganglion cells in culture
68. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain
69. 2+ flux in mammalian central neurons
70. Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing
71. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro
72. Excitatory amino acid involvement in retinal degeneration
73. Apoptosis is induced by excitotoxicity in goldfish retina
74. Chronic low-dose glutamate is toxic to retinal ganglion cells
75. Preferential co-assembly of recombinant NMDA receptors composed of three different subunits
76. AMPA/kainate receptor-mediated damage to NADPH-diaphorase containing neurons is Ca++ dependent
77. N-Methyl-D-aspartate receptors containing the NR2D subunit in the retina are selectively expressed in rod bipolar cells
78. Developmental and regional expression of NMDA receptor subtypes containing the NR2D subunit in the rat brain
79. Maturation of a central glutamatergic synapse
80. Quantitation of rat dopamine transporter mRNA: Effects of cocaine treatment and withdrawal
81. Transient global ischemia alters NMDA receptor expression in rat hippocampus: Correlation with decreased immunoreactive protein levels of the NR2A/2B subunits, and an altered NMDA receptor functionality